for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Astrazeneca Pharma India Ltd

ASTR.NS

Latest Trade

2,300.00INR

Change

0.75(+0.03%)

Volume

4,730

Today's Range

2,285.30

 - 

2,344.00

52 Week Range

1,306.05

 - 

2,397.70

As of on the National Stock Exchange of India ∙ Minimum 15 minute delay

Pricing

Previous Close
2,299.25
Open
2,308.75
Volume
4,730
3M AVG Volume
0.44
Today's High
2,344.00
Today's Low
2,285.30
52 Week High
2,397.70
52 Week Low
1,306.05
Shares Out (MIL)
25.00
Market Cap (MIL)
54,971.25
Forward P/E
--
Dividend (Yield %)
--

Next Event

Q2 2020 Astrazeneca Pharma India Ltd Earnings Release

Latest Developments

More

Astrazeneca Pharma India Gets Import, Market Permission For Dapagliflozin + Saxagliptin Film Coated Tablets

Bioton Books Impairment Loss To Affect Its H1 Net Result

Astrazeneca Pharma India June-Qtr Profit Rises

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Astrazeneca Pharma India Ltd

AstraZeneca Pharma India Limited is a global biopharmaceutical company. The Company is engaged in the discovery, development and commercialization of medicines for core areas of healthcare, including cardiovascular/metabolic disease, cancer and respiratory, inflammatory and autoimmune disease. The Company operates through two segments: Healthcare and Clinical Trial. The Healthcare segment engages in the manufacture and sale of pharmaceutical products. The Clinical Trial segment renders clinical trial services on pharmaceutical products to its group companies. It has presence in over seven areas of healthcare, including diabetes, oncology, infection, local anesthesia and maternal healthcare. The principal products/services of the Company are Meronem and Brilinta/Axcer. Its pipeline includes products, such as AZD4076, MEDI6012, AZD2811, MEDI0680, selumetinib, anifrolumab and MEDI7510. Its brands include Crestor, Seloken XL, Meronem, Arimidex, Zoladex, Nexium and Brilinta.

Industry

Major Drugs

Contact Info

Ni 12Th Floor, Manyata Empassy Business

Park Rachenahalli,Outer Ring Rd Kr Puram

Hebbal

+91.80.67748000

https://www.astrazeneca.com/country-sites/india.html

Executive Leadership

Darius Erach Udwadia

Non-Executive Independent Chairman of the Board

Rajesh Marwaha

Chief Financial Officer, Acting Compliance Officer, Whole Time Director

Pratap Rudra

Compliance Officer, Company Secretary

Gagan Singh Bedi

Managing Director, Director

Sanjay Murdeshwar

Managing Director, Director

Key Stats

2.00 mean rating - 1 analysts
Sell
Hold
Buy
Revenue (MM, INR)

2020(E)

8.3K
EPS (INR)

2020(E)

25.340
Price To Earnings (TTM)
79.00
Price To Sales (TTM)
7.13
Price To Book (MRQ)
--
Price To Cash Flow (TTM)
64.24
Total Debt To Equity (MRQ)
--
LT Debt To Equity (MRQ)
--
Return on Investment (TTM)
--
Return on Equity (TTM)
--

Latest News

Latest News

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up